Literature DB >> 15067695

Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers.

Fuxing Tang1, Hui Ouyang, Jerry Z Yang, Ronald T Borchardt.   

Abstract

The bidirectional permeation characteristics of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein (P-gp), across monolayers of MDCK cells transfected with the human MDR1 gene (MDCK-MDR1) were investigated. The ratios of the apparent permeability coefficients (P(app)) of rhodamine 123 and Hoechst 33342 flux measured in the basolateral (BL) to apical (AP) direction versus the flux in the AP-to-BL direction (P(app BL-to-AP)/P(app AP-to-BL)) were 115 and 177, respectively. The P-gp inhibitor GF-120918 could significantly reduce the polarized efflux of both rhodamine 123 and Hoechst 33342. Rhodamine 123 appeared to "stimulate" the polarized efflux of Hoechst 33342 across MDCK-MDR1 cell monolayers. In contrast, Hoechst 33342 partially inhibited the polarized efflux of rhodamine 123 across these cell monolayers whereas daunorubicin partially inhibited the polarized efflux of both rhodamine 123 and Hoechst 33342. The uptake characteristics of rhodamine 123 and Hoechst 33342 in MDCK-MDR1 cells were measured in the absence and presence of GF-120918 and known P-gp substrates (Hoechst 33342, rhodamine 123, and daunorubicin). The uptake of rhodamine 123 and Hoechst 33342 in MDCK-MDR1 cells was enhanced more than twofold by inclusion of GF-120918 (2 microM) in the incubation medium. Daunorubicin (160 microM) increased the relative fluorescence unit (RFU) values of cytoplasm-associated rhodamine 123 by up to 30%. However, daunorubicin (40 microM) and rhodamine 123 (5 microM) decreased the RFU values of cell membrane-associated Hoechst 33342 by 70% and 40%, respectively. To further explore what appears to be a "stimulatory" effect of daunorubicin and rhodamine 123 on the uptake of Hoechst 33342 and a stimulatory effect of daunorubicin on Hoechst 33342 transport across cell monolayer, uptake of Hoechst 33342 into liposomes in the presence and absence of GF-120918, daunorubicin, and rhodamine 123 was determined. GF-120918 exhibited no effect on the RFU values of liposome-associated Hoechst 33342. In contrast, rhodamine 123 and daunorubicin decreased the fluorescence of liposome-associated Hoechst 33342 suggesting these molecules were either quenching the fluorescence of this chemical probe or displacing it from the lipid bilayer. In conclusion, these bidirectional transport data indicate that rhodamine 123 and Hoechst 33342 are excellent substrates of P-gp in MDCK-MDR1 cells. The ability of Hoechst 33342 to partially inhibit the polarized efflux of rhodamine 123 is consistent with these substrates binding to the same site on P-gp. In contrast, the ability of rhodamine 123 to apparently "stimulate" the efflux of Hoechst 33342 in both the transport and uptake experiments suggests the substrates might bind to different sites on P-gp. However, experimental results using liposomes suggested that this "stimulation" phenomenon by rhodamine 123 on Hoechst 33342 uptake and efflux might simply be an artifact. Thus, the use of Hoechst 33342 to probe the binding sites on a membrane-bound protein such as P-gp might be problematic. Copyright 2004 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:1185-1194, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067695     DOI: 10.1002/jps.20046

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  15 in total

1.  Effect of five novel 5-substituted tetrandrine derivatives on P-glycoprotein-mediated inhibition and transport in Caco-2 cells.

Authors:  Zhonglian Cao; Dan Li; Li Liu; Ping Yang
Journal:  Oncol Lett       Date:  2018-09-24       Impact factor: 2.967

2.  Frequency of MDR1-related p-gp overexpression in Greek Leishmania isolates.

Authors:  Johannes Austrup; Pantelis Ntais; Vasiliki Christodoulou; Jean-Pierre Dedet; Francine Pratlong; Maria Antoniou
Journal:  Parasitol Res       Date:  2014-02-07       Impact factor: 2.289

Review 3.  The ability of molecular docking to unravel the controversy and challenges related to P-glycoprotein--a well-known, yet poorly understood drug transporter.

Authors:  Maen Zeino; Mohamed E M Saeed; Onat Kadioglu; Thomas Efferth
Journal:  Invest New Drugs       Date:  2014-04-22       Impact factor: 3.850

Review 4.  ABC drug transporter at the blood-brain barrier: effects on drug metabolism and drug response.

Authors:  Martin Ebinger; Manfred Uhr
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08       Impact factor: 5.270

5.  Hydrogel-assisted functional reconstitution of human P-glycoprotein (ABCB1) in giant liposomes.

Authors:  Kim S Horger; Haiyan Liu; Divya K Rao; Suneet Shukla; David Sept; Suresh V Ambudkar; Michael Mayer
Journal:  Biochim Biophys Acta       Date:  2014-11-04

6.  Functional characterization of sodium-dependent multivitamin transporter in MDCK-MDR1 cells and its utilization as a target for drug delivery.

Authors:  Shuanghui Luo; Viral S Kansara; Xiaodong Zhu; Nanda K Mandava; Dhananjay Pal; Ashim K Mitra
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

7.  Targeted lipid based drug conjugates: a novel strategy for drug delivery.

Authors:  Aswani Dutt Vadlapudi; Ramya Krishna Vadlapatla; Deep Kwatra; Ravinder Earla; Swapan K Samanta; Dhananjay Pal; Ashim K Mitra
Journal:  Int J Pharm       Date:  2012-06-09       Impact factor: 5.875

8.  Permeability of rhynchophylline across human intestinal cell in vitro.

Authors:  Bo Ma; Jing Wang; Jing Sun; Ming Li; Huibo Xu; Guibo Sun; Xiaobo Sun
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

9.  Stereoselective Regulation of P-gp Activity by Clausenamide Enantiomers in Caco-2, KB/KBv and Brain Microvessel Endothelial Cells.

Authors:  Chuan-Jiang Zhu; Fang Hua; Xiao-Lu Zhu; Meng Li; Hong-Xu Wang; Xiao-Ming Yu; Yan Li
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

10.  Purvalanol A, olomoucine II and roscovitine inhibit ABCB1 transporter and synergistically potentiate cytotoxic effects of daunorubicin in vitro.

Authors:  Daniela Cihalova; Jakub Hofman; Martina Ceckova; Frantisek Staud
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.